University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Jonathan Singer, M.D.

Pulmonologist

Dr. Jonathan Singer is a pulmonologist and critical care specialist in the Lung Transplant Program who treats patients with advanced lung disease, before and after lung transplants. He treats conditions such as idiopathic pulmonary fibrosis, interstitial lung disease (ILD), connective-tissue disease associated with ILD, hypersensitivity pneumonitis, cystic fibrosis and chronic obstructive pulmonary disease.

In his research, he studies outcomes in lung transplantation and how lung transplants improve function, reduces disability and improves health-related quality of life. A second area of research is employing advanced statistical modeling techniques to identify pre-transplant risk factors associated with important outcomes following lung transplantation. Singer earned a medical degree and master's of science degree in the joint UC Berkeley and UCSF program. He completed a residency at UCSF in internal medicine and fellowships in pulmonary and critical care medicine and lung and heart-lung transplantation, both at UCSF. He is a member of the American Thoracic Society, International Society for Heart and Lung transplantation, American College of Chest Physicians and European Respiratory Society. Singer is board certified in internal medicine, pulmonary medicine and critical care medicine. He is a clinical instructor of medicine at UCSF.

Clinics

Lung Transplant Program
400 Parnassus Ave., Sixth Floor
San Francisco, CA 94143
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: Thursday 8 a.m. – 5 p.m. (exact times vary depending on number of physicians in clinic)

Conditions & Treatments

More about Jonathan Singer

Education

UCSF Medical Center School of Medicine 2004

Residencies

UC San Francisco Medical Center 2007

Fellowships

UC San Francisco Medical Center 2010

Selected Research and Publications

  1. Singer JP, Peterson ER, Snyder ME, Katz PP, Golden JA, D'Ovidio F, Bacchetta M, Sonett JR, Kukreja J, Shah L, Robbins H, Van Horn K, Shah RJ, Diamond JM, Wickersham N, Sun L, Hays S, Arcasoy SM, Palmer SM, Ware LB, Christie JD, Lederer DJ. Body Composition and Mortality after Adult Lung Transplantation in the United States. Am J Respir Crit Care Med. 2014 Sep 18.
  2. Kern RM, Seethamraju H, Blanc PD, Sinha N, Loebe M, Golden J, Kukreja J, Scheinin S, Hays S, Kleinhenz ME, Leard L, Hoopes C, Singer JP. The Feasibility of Lung Transplantation in HIV-Seropositive Patients. Ann Am Thorac Soc. 2014 Jul; 11(6):882-9.
  3. Ware LB, Landeck M, Koyama T, Zhao Z, Singer J, Kern R, Neidlinger N, Nguyen J, Johnson E, Janz DR, Bernard GR, Lee JW, Matthay MA. A randomized trial of the effects of nebulized albuterol on pulmonary edema in brain-dead organ donors. Am J Transplant. 2014 Mar; 14(3):621-8.
  4. Greenland JR, Jewell NP, Gottschall M, Trivedi NN, Kukreja J, Hays SR, Singer JP, Golden JA, Caughey GH. Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection. Am J Transplant. 2014 Apr; 14(4):831-40.
  5. Hui C, Kern RM, Wojciechowski D, Kukreja J, Golden JA, Hays SR, Singer JP. Use of Belatacept in a Lung Transplant Recipient. J Invest Med High Impact Case Reports. 2014; (Jul-Sept):1-3.
  6. Williams K, Mansh M, Chin-Hong P, Singer J, Arron ST. Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients. Clin Infect Dis. 2014 Apr; 58(7):997-1002.
  7. Singer JP, Blanc PD, Dean YM, Hays S, Leard L, Kukreja J, Golden J, Katz PP. Development and validation of a lung transplant-specific disability questionnaire. Thorax. 2014 May; 69(5):445-50.
  8. Singer JP, Singer LG. Quality of life in lung transplantation. Semin Respir Crit Care Med. 2013 Jun; 34(3):421-30.
  9. Sottile PD, Iturbe D, Katsumoto TR, Connolly MK, Collard HR, Leard LA, Hays S, Golden JA, Hoopes C, Kukreja J, Singer JP. Outcomes in systemic sclerosis-related lung disease after lung transplantation. Transplantation. 2013 Apr 15; 95(7):975-80.
  10. Singer JP, Chen J, Blanc PD, Leard LE, Kukreja J, Chen H. A thematic analysis of quality of life in lung transplant: the existing evidence and implications for future directions. Am J Transplant. 2013 Apr; 13(4):839-50.
  11. Sayah DM, Schwartz BS, Kukreja J, Singer JP, Golden JA, Leard LE. Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis. Transpl Infect Dis. 2013 Apr; 15(2):E70-4.
  12. Sayah DM, Koff JL, Leard LE, Hays SR, Golden JA, Singer JP. Rhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection. Clin Transplant. 2013 Jan-Feb; 27(1):E64-71.
  13. Singer JP, Yusen RD. Defining patient-reported outcomes in chronic obstructive pulmonary disease: the patient-centered experience. Med Clin North Am. 2012 Jul; 96(4):767-87.
  14. Singer JP, Katz PP, Iribarren C, Omachi TA, Sanchez G, Yelin EH, Cisternas MG, Blanc PD. Both pulmonary and extra-pulmonary factors predict the development of disability in chronic obstructive pulmonary disease. Respiration. 2013; 85(5):375-83.
  15. Zutler M, Singer JP, Omachi TA, Eisner M, Iribarren C, Katz P, Blanc PD. Relationship of obesity with respiratory symptoms and decreased functional capacity in adults without established COPD. Prim Care Respir J. 2012 Jun; 21(2):194-201.
  16. Singer JP, Boker A, Metchnikoff C, Binstock M, Boettger R, Golden JA, Glidden DV, Arron ST. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients. J Heart Lung Transplant. 2012 Jul; 31(7):694-9.
  17. Wiita AP, Roubinian N, Khan Y, Chin-Hong PV, Singer JP, Golden JA, Miller S. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis. Transpl Infect Dis. 2012 Jun; 14(3):248-58.
  18. Watkins KD, Boettger RF, Hanger KM, Leard LE, Golden JA, Hoopes CW, Singer JP. Use of sublingual tacrolimus in lung transplant recipients. J Heart Lung Transplant. 2012 Feb; 31(2):127-32.
  19. Smith L, Singer JP, Hayes M, Golden JA, Leard LE. An analysis of potential risk factors for early complications from fiberoptic bronchoscopy in lung transplant recipients. Transpl Int. 2012 Feb; 25(2):172-8.
  20. Singer JP, Chen H, Phelan T, Kukreja J, Golden JA, Blanc PD. Survival following lung transplantation for silicosis and other occupational lung diseases. Occup Med (Lond). 2012 Mar; 62(2):134-7.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.